Selecta Biosciences - Company & Market Research Reports

Selecta Biosciences was founded in 2007 and is headquartered in Watertown, Massachusetts. It is a biopharmaceutical company, they create biological therapies that fight against unwanted immune responses. Selecta Biosciences specialise in Synthetic Vaccine Particles (SVP™) technology platform. They use this treatment to fight rare and serious diseases. Selectas current pipeline includes: SVP- enabled enzyme, oncology and gene therapies.

From
From
From
From
From
From
From
From
From
From
From
From
From
From
Chlamydia Infections - Pipeline Insight, 2018 - Product Thumbnail Image

Chlamydia Infections - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1051 Pages
From
Rheumatoid Arthritis - Pipeline Review, H1 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • Drug Pipelines
  • 1020 Pages
From
Celiac Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Celiac Disease - Pipeline Review, H1 2018

  • Drug Pipelines
  • 83 Pages
From
Cervical Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Cervical Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 768 Pages
From
From
Loading Indicator
adroll